| Mary C Wente, LMFT LCSW | |
|
212 S 11th St, Lacrosse, WI 54601 | |
| (608) 791-9555 | |
| (608) 791-9432 |
| Full Name | Mary C Wente |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 212 S 11th St, Lacrosse, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932147733 | NPI | - | NPPES |
| 39223800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 2863 (Wisconsin) | Primary |
| 106H00000X | Marriage & Family Therapist | 222 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary C Wente, LMFT LCSW 700 West Ave S, Attn Physican Services, Lacrosse, WI 54601 Ph: (608) 791-4156 | Mary C Wente, LMFT LCSW 212 S 11th St, Lacrosse, WI 54601 Ph: (608) 791-9555 |
News Archive
The U.S. Food and Drug Administration has issued an import alert regarding entry of cantaloupe from Agropecuaria Montelibano, a Honduran grower and packer, because, based on current information, fruit from this company appears to be associated with a Salmonella Litchfield outbreak in the United States and Canada.
Today, Lung Cancer Alliance (LCA) commended Senator Olympia Snowe (R-ME) and Congresswoman Chellie Pingree (D-ME) for joining Congressman Michael Michaud (D-ME) as cosponsors of the Lung Cancer Mortality Reduction Act (LCMRA), a bi-partisan, bi-cameral bill that establishes the first ever multi-agency, comprehensive research program targeting all aspects of lung cancer.
Tumor necrosis factor inhibitors (TNFis) are used to treat inflammatory conditions, such as RA. These agents work by blocking TNF, an important mediator of inflammation in RA, in order to help reduce inflammation and stop disease progression.
New research published by the American Psychological Association has found that the rate of certain mental health disorders has increased significantly over the last decade among young adults, but not among older adults.
Dartmouth engineers have been awarded a $2.5 million grant from the National Cancer Institute, part of the National Institutes of Health, to develop and test a device-a microendoscopic electrical impedance sensing probe- that could be used by surgeons to detect prostate cancer still left in the body during surgery.
› Verified 1 days ago